When switching from one DOAC to another DOAC, should you overlap therapy?

Study for the Anticoagulation and ACS Exam with tailored flashcards and multiple choice questions, each featuring hints and detailed explanations. Prepare effectively and ensure success on your exam with confidence!

Multiple Choice

When switching from one DOAC to another DOAC, should you overlap therapy?

Explanation:
The main idea is that switching between DOACs should be done without overlap. Each DOAC provides rapid onset and has a relatively short duration of action, so stacking two DOACs at the same time would significantly increase bleeding risk without added benefit. The correct approach is to stop the first DOAC and start the second DOAC at the time the second agent would be due, ensuring continuous protection without overlap. Bridging with a parenteral agent is not required when moving between DOACs. If a procedure or special circumstance arises, follow per-drug hold guidelines, but for routine switching there’s no overlap.

The main idea is that switching between DOACs should be done without overlap. Each DOAC provides rapid onset and has a relatively short duration of action, so stacking two DOACs at the same time would significantly increase bleeding risk without added benefit. The correct approach is to stop the first DOAC and start the second DOAC at the time the second agent would be due, ensuring continuous protection without overlap. Bridging with a parenteral agent is not required when moving between DOACs. If a procedure or special circumstance arises, follow per-drug hold guidelines, but for routine switching there’s no overlap.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy